title: KL-6 and poor prognosis in NSCLC patients treated with gefitinib.
authors.forename: Gen
authors.initials: G
authors.lastname: Ohara
authors.forename: Koichi
authors.initials: K
authors.lastname: Kurishima
authors.forename: Hiroichi
authors.initials: H
authors.lastname: Ishikawa
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Satoh
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Hizawa
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D018396:Mucin-1 / Q000097:blood*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; C060192:MUC1 protein, human; D018396:Mucin-1; D011799:Quinazolines; D000077156:Gefitinib